This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pyrexia in children

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Pyrexia is a physiological response to illness, and may be is due to an increase in the set point of temperature in the hypothalamic regulatory centre. Older children suffer higher fevers than neonates in whom mechanical thermogenesis by shivering is limited.

There is little evidence that reducing fever improves the outcome of childhood infections. It is not clear if fever act as a defence against infection but what evidence there is suggests it does.

Some pathogens such as Strep.pneumoniae may be directly inhibited by fever.

Notes (1):

  • NICE state that:

    • recognise that children younger than 3 months with a temperature of 38°C or higher are in a high-risk group for serious illness

    • recognise that children aged 3-6 months with a temperature of 39°C or higher are in at least an intermediate-risk group for serious illness

  • do not use duration of fever to predict the likelihood of serious illness. However, children with a fever lasting 5 days or longer should be assessed for Kawasaki disease
  • think "Could this be sepsis?" and refer to the NICE guideline on sepsis: recognition, diagnosis and early management if a child presents with fever and symptoms or signs that indicate possible sepsis
    • sepsis is a condition of life-threatening organ dysfunction due to a dysregulated host response to infection

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.